Article
Cannabinoids and the gut: new developments and emerging concepts.
Pharmacology & therapeutics - 1 Apr 2010
Izzo Angelo A, Sharkey Keith A
Abstract excerpt
Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric infections and inflammatory conditions to disorders of motility, emesis and abdominal pain. The mechanistic basis of these treatments emerged after the discovery of Delta(9)-tetrahydrocannabinol as the major constituent of Cannabis. Further progress was made when the receptors for Delta(9)-tetrahydrocannabinol were identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
